Skip to main content
Clinical Trials/NCT05957562
NCT05957562CompletedNot Applicable

Azygos Vein Preservation Revisited: Impact on Early Outcomes After Repair of Esophageal Atresia/ Tracheo-Esophageal Fistula in Newborns: A Randomized Controlled Study

dr. Muhammad Abdelhafez Mahmoud, MD2 sites in 1 country64 target enrollmentStarted: April 10, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
64
Locations
2
Primary Endpoint
gap between the pouches after mobilization

Study Overview

Brief Summary

Azygos vein preservation revisited: impact on early outcomes after repair of Esophageal atresia/ Tracheo-Esophageal Fistula in newborns. A randomized controlled study.

Detailed Description

Since the first successful repair of esophageal atresia/tracheoesophageal fistula was performed approximately eight decades ago, surgeons have made considerable technical advances in solving intraoperative surgical challenges and reducing postoperative complications. According to some surgeons, the advantage of maintaining the Azygos vein makes this modification attractive. This study aimed to explore the benefits of retaining the Azygos vein during surgery for Esophageal Atresia with tracheoesophageal fistula, to emphasize its advantages in terms of reducing anastomotic leak, stricture, and other postoperative outcomes.

Patients and Methods: This prospective randomized study was conducted between April 2020 and April 2023. The study included all newborns with (EA & TEF) eligible for primary repair, patients were randomly assigned to either Group A or Group B. (Group A) patients who underwent Azygos vein preservation during TEF repair, whereas the remaining patients (Group B) had Azygos vein disconnection.

Statistical analysis

The Statistical Package for Social Sciences (SPSS) (version 23.0, IBM Corp IBM Corp., Armonk, NY, USA) was used for statistical analysis. The chi-square test (X2) was used to compare qualitative data in the groups, while an independent-sample t-test was used to compare quantitative data between groups. The degree of confidence was set at 95%. The p-value was considered significant at a level of 0.05.

Discussion: will focus on advantages of azygous vein preservation on intactness of esophageal anastomosis, retaining the venous drainage of the bronchial system, and chest wall. Points of discussion will include effects of Azygous vein preservation on incidence of postoperative pneumonitis, anastomotic leakage and stricture rate, and mortality rate. The results obtained from this study will be compared between both groups and with those reported in the literature.

Finally, the investigators will conclude the reconstructive technique that gives the better results and least morbidity.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Masking Description

single (participants will choose from sealed closed envelopes)

Eligibility Criteria

Ages
1 Day to 28 Days (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • all neonates suitable for primary repair of Esophageal Atresia and tracheoesophageal fistula

Exclusion Criteria

  • long gap esophageal atresia (> 3 cm)
  • esophageal atresia without tracheoesophageal fistula

Outcomes

Primary Outcomes

gap between the pouches after mobilization

Time Frame: 2 years

missed distance between the mobilized esophageal pouches in centimeters

mortality

Time Frame: 35 months

mortality rate in number

early postoperative pneumonia

Time Frame: 35 months

postoperative pneumonitis in number

operative time

Time Frame: 2 years

operative time in minutes

early postoperative anastomotic leak

Time Frame: 35 months

anastomotic leakage rate in number

early postoperative anastomotic stricture

Time Frame: 35 months

anastomotic stricture rate in number

Secondary Outcomes

  • sex(2 years)
  • associated congenital anomalies(2 years)
  • gestational age(2 years)
  • associated anomalies(2 years)

Investigators

Sponsor
dr. Muhammad Abdelhafez Mahmoud, MD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

dr. Muhammad Abdelhafez Mahmoud, MD

Lecturer of pediatric surgery, Al-Azhar Faculty of Medicine

Al-Azhar University

Study Sites (2)

Loading locations...

Similar Trials